<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007360.ref009">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Lin</surname>
   <given-names>KL</given-names>
  </name>, 
  <name>
   <surname>Sweeney</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Kang</surname>
   <given-names>BD</given-names>
  </name>, 
  <name>
   <surname>Ramsburg</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Gunn</surname>
   <given-names>MD</given-names>
  </name>. 
  <article-title>CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection</article-title>. 
  <source>J Immunol</source>. 
  <year>2011</year>;
  <volume>186</volume>:
  <fpage>508</fpage>â€“
  <lpage>515</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.1001002</pub-id>
  <?supplied-pmid 21098218?>
  <pub-id pub-id-type="pmid">21098218</pub-id>
 </mixed-citation>
</ref>
